Healthcare Industry News: Invatec
News Release - June 4, 2009
Custom Spine Welcomes Randal Clarke as Vice President of SalesPARSIPPANY, N.J., June 4 -- (Healthcare Sales & Marketing Network) -- Custom Spine announced today that Randal Clarke is the new Vice President of Sales for the Western region. Randy has been in the orthopedic medical device market for over 27 years and has expertise in developing markets for new products and building successful start-up organizations.
Randy's career began as a sales representative for Zimmer, which was followed by a sales career at LInvatec. He then started Advanced Orthopedic Systems, a distribution company for orthopedic products from LInvatec sports medicine, Bionx and Hall Surgical Power with revenue in excess of $11 million. Randy also held management positions at two companies in the emerging technology field, Osteobiologics and ConforMIS, where he was an integral part of the strategic launch of new product lines for both companies. While at Osteobiologics, Randy also helped ensure a smooth transition in the Smith & Nephew purchase of Osteobiologics through sales training and support.
Lew Bennett, President of Custom Spine, recently stated: "Randy will be a great asset to our management team. His vast knowledge of the orthopedic industry combined with his experience of distributorships and management of developing markets, will further support Custom Spine's growth initiative."
About Custom Spine
Custom Spine, Inc. is a pioneering leader in the spine market creating the next generation of surgeon-friendly spinal implants and instruments that provide superior performance and patient care. The company was founded by top engineers and industry professionals in partnership with orthopedic and neurological spine surgeons to develop advanced medical solutions. Custom Spine (www.customspine.com) is a privately held company headquartered in Parsippany, New Jersey. For more information, please contact 1-973-808-0019.
Source: Custom Spine
Issuer of this News Release is solely responsible for its
Please address inquiries directly to the issuing company.